RATINGS CHANGES

AmerisourceBergen (ABC - Get Report) was upgraded to outperform at Leerink. $95 price target. The Rite Aid deal will likely go through and industry price regulation risks have eased, Leerink said. 

Agios Pharmaceuticals (AGIO - Get Report) was upgraded to outperform from perform at Oppenheimer. $75 price target. Analysts have higher expectations for the company's new potential hematology drugs, Oppenheimer said. 

Boston Scientific (BSX - Get Report) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: BSX.

Continental Resources (CLR - Get Report) was upgraded to buy from underperform at Jefferies. $60 price target. The Bakken should drive growth in the coming quarters, Jefferies said. 

Chipotle Mexican Grill (CMG - Get Report) was downgraded to neutral from overweight at J.P. Morgan. $375 price target. The company is facing a difficult path in the near-term. 

Disney (DIS - Get Report) was upgraded to buy from neutral at Goldman Sachs. $134 price target. Film slate and new theme park attractions should drive growth, Goldman said. 

Brinker (EAT - Get Report) was downgraded to underweight at Morgan Stanley. Earnings estimates were also reduced, given lower sales expectations, Morgan Stanley said.

JPMorgan Chase (JPM - Get Report) was downgraded to market perform from outperform at Keefe, Bruyette & Woods. $88 price target. The company lacks near-term catalysts. 

MSC Industrial (MSM - Get Report) was upgraded to neutral from underperform at Credit Suisse. $90 price target. The company is leveraged to a recovery in manufacturing activity, Credit Suisse said. 

NQ Mobile (NQ) was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: NQ.

Outfront Media (OUT - Get Report) was downgraded to neutral from buy at Goldman Sachs. $27 price target. The valuation is less attractive, relative to Lamar Advertising at current levels, Goldman said. 

This article was written by a staff member of TheStreet.